Cargando…

Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure

Background: The inhibition of sodium-glucose co-transporter 2 (SGLT-2) has been shown to be beneficial in the treatment of diabetic and non-diabetic patients with heart failure. The underlying mechanisms are incompletely understood. The present prospective study investigates for the first time the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Gotzmann, Michael, Henk, Pauline, Stervbo, Ulrik, Blázquez-Navarro, Arturo, Mügge, Andreas, Babel, Nina, Westhoff, Timm H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342830/
https://www.ncbi.nlm.nih.gov/pubmed/37445494
http://dx.doi.org/10.3390/jcm12134458

Ejemplares similares